Top Markets
Coin of the day
Elbit Medical Technologies Ltd Elbit Medical Technologies Ltd

Elbit Medical Technologies Ltd

EMTC-M
Rang in Aktien #40898
Elbit Medical Technologies Ltd functions as an investment holding company, with... Elbit Medical Technologies Ltd functions as an investment holding company, with its core activities centered on the innovation, production, and global commercialization of therapeutic medical devices. The company maintains a presence across the United States, Europe, and other international territories. A key initiative involves the advancement of a magnetic resonance imaging (MRI) guided focused ultrasound treatment system, designed to tackle a range of medical challenges, including various cancers (oncology), gynecological conditions, neurological disorders, and tumors. Additionally, Elbit Medical Technologies is engaged in the extensive study and creation of medical products leveraging stem cells, predominantly sourced from umbilical cord blood. These stem cell applications are critical for bone marrow transplants in individuals affected by leukemia, lymphatic system cancers, non-malignant hematological diseases, and inherited metabolic genetic conditions. Headquartered in Petah Tikva, Israel, Elbit Medical Technologies Ltd is a wholly-owned subsidiary of Exigent Management Ltd.
Aktienkurs
$0.07188945
Zuletzt synchronisiert: 2026-02-17
Marktkapitalisierung
$65.22K
Veränderung (1 Tag)
-7.50%
Veränderung (1 Jahr)
10.44%
Land
IL
Handel Elbit Medical Technologies Ltd (EMTC-M)

Kategorie

P/B-Verhältnis für Elbit Medical Technologies Ltd (EMTC-M)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Elbit Medical Technologies Ltd beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für Elbit Medical Technologies Ltd von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
3.6048 -
US
5.207 -
US
2.0146 -
IE
2.6697 -
US
4.8038 -
US